SCHEMBL13288663

SCHEMBL13288663

Bc1cnn2c(NCc3cccc(NC(=O)c4ccc(C#N)cc4)c3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 5/20 0.47
▸ GSK3B P49841 5/20 0.47
▸ AURKA O14965 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PRKAA2 P54646 1/20 0.39
▸ ACKR3 P25106 1/20 0.39
▸ ITK Q08881 1/20 0.38
▸ ABL1 P00519 2/20 0.38
▸ PDGFRB P09619 1/20 0.38
▸ BCR P11274 1/20 0.38
▸ PDGFRA P16234 1/20 0.38
▸ PRKCA P17252 1/20 0.38
▸ RET P07949 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13288665 0.93 CDK2 (0.46) CDK2GSK3BACKR3MAPT
SCHEMBL14581256 0.92 AURKA (0.45) CDK2GSK3BAURKAAURKBMEN1
SCHEMBL13119679 0.92 CDK2 (0.58) CDK2GSK3BAURKAAURKB
SCHEMBL13289326 0.92 CDK2 (0.47) CDK2GSK3BAURKAAURKBMEN1
SCHEMBL13288642 0.90 CDK2 (0.49) CDK2GSK3BRETKDR
SCHEMBL13289323 0.89 CDK2 (0.48) CDK2GSK3BAURKAAURKBMEN1
SCHEMBL13288878 0.88 CDK2 (0.49) CDK2GSK3BMEN1NPC1RAB9A
SCHEMBL13289130 0.88 RET (0.48) CDK2GSK3BAURKAAURKBMEN1
SCHEMBL13288729 0.86 CDK2 (0.51) CDK2GSK3BMEN1KMT2A
SCHEMBL13288880 0.86 CDK2 (0.44) CDK2GSK3BABL1RETKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback